Live Breaking News & Updates on ஜேசன் அசாத்|Page 8

Stay updated with breaking news from ஜேசன் அசாத். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cyclacel Pharmaceuticals Prices $12.65 Million Underwritten Public Offering of Common Stock


Message :
Required fields
BERKELEY HEIGHTS, N.J., March 12, 2021 (GLOBE NEWSWIRE) Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; Cyclacel or the Company ), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the pricing of an underwritten public offering of 1,807,143 shares of its common stock, offered at a price of $7.00 to the public. Additionally, the Company has granted the underwriters a 30-day option to purchase up to an additional 271,071 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares in the offering are being offered by the Company. The offering is expected to close on or about March 16, 2021, subject to customary closing conditions. The gross proceeds to the Company from this offering are expected to be approximately $12.65 million, before deducting underwriting discounts and commissions and other estimated offering expen ....

New York , United States , Paul Mcbarron , Jason Assad , Exchange Commission , Syndicate Prospectus Department , Cyclacel Pharmaceuticals Inc , Arcadia Securities , Thalmann Co , Oppenheimer Co , Capital Partners , Capital Markets , Cyclacel Pharmaceuticals , Annual Report , All Rights , Inc Stock Exchange , Press Release , Announced Cycc , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஜேசன் அசாத் , பரிமாற்றம் தரகு , கூட்டமைப்பு ப்ரோஸ்பெக்டஸ் துறை , ஆர்கேடியா பத்திரங்கள் , ஆபெந்ஹைமர் இணை , மூலதனம் கூட்டாளர்கள் ,